366 related articles for article (PubMed ID: 17544263)
21. Regulation by complement C3a and C5a anaphylatoxins of cytokine production in human umbilical vein endothelial cells.
Monsinjon T; Gasque P; Chan P; Ischenko A; Brady JJ; Fontaine MC
FASEB J; 2003 Jun; 17(9):1003-14. PubMed ID: 12773483
[TBL] [Abstract][Full Text] [Related]
22. A new mechanism regulating the initiation of allergic airway inflammation.
Kiss A; Montes M; Susarla S; Jaensson EA; Drouin SM; Wetsel RA; Yao Z; Martin R; Hamzeh N; Adelagun R; Amar S; Kheradmand F; Corry DB
J Allergy Clin Immunol; 2007 Aug; 120(2):334-42. PubMed ID: 17544098
[TBL] [Abstract][Full Text] [Related]
23. The receptor for complement anaphylatoxin C3a is expressed by myeloid cells and nonmyeloid cells in inflamed human central nervous system: analysis in multiple sclerosis and bacterial meningitis.
Gasque P; Singhrao SK; Neal JW; Wang P; Sayah S; Fontaine M; Morgan BP
J Immunol; 1998 Apr; 160(7):3543-54. PubMed ID: 9531317
[TBL] [Abstract][Full Text] [Related]
24. TNF-alpha-mediated expression of the receptor for anaphylatoxin C5a on neurons in experimental Listeria meningoencephalitis.
Stahel PF; Frei K; Eugster HP; Fontana A; Hummel KM; Wetsel RA; Ames RS; Barnum SR
J Immunol; 1997 Jul; 159(2):861-9. PubMed ID: 9218605
[TBL] [Abstract][Full Text] [Related]
25. The involvement of type 1a angiotensin II receptors in the regulation of airway inflammation in a murine model of allergic asthma.
Ohwada K; Watanabe K; Okuyama K; Ohkawara Y; Sugaya T; Takayanagi M; Ohno I
Clin Exp Allergy; 2007 Nov; 37(11):1720-7. PubMed ID: 17877756
[TBL] [Abstract][Full Text] [Related]
26. Mast cell anaphylatoxin receptor expression can enhance IgE-dependent skin inflammation in mice.
Schäfer B; Piliponsky AM; Oka T; Song CH; Gerard NP; Gerard C; Tsai M; Kalesnikoff J; Galli SJ
J Allergy Clin Immunol; 2013 Feb; 131(2):541-8.e1-9. PubMed ID: 22728083
[TBL] [Abstract][Full Text] [Related]
27. C3a and C5a receptor antagonists ameliorate endothelial-myofibroblast transition via the Wnt/β-catenin signaling pathway in diabetic kidney disease.
Li L; Chen L; Zang J; Tang X; Liu Y; Zhang J; Bai L; Yin Q; Lu Y; Cheng J; Fu P; Liu F
Metabolism; 2015 May; 64(5):597-610. PubMed ID: 25682062
[TBL] [Abstract][Full Text] [Related]
28. C5a promotes development of experimental lupus nephritis which can be blocked with a specific receptor antagonist.
Bao L; Osawe I; Puri T; Lambris JD; Haas M; Quigg RJ
Eur J Immunol; 2005 Aug; 35(8):2496-506. PubMed ID: 16052609
[TBL] [Abstract][Full Text] [Related]
29. Distinct roles of the anaphylatoxins C3a and C5a in dendritic cell-mediated allergic asthma.
Engelke C; Wiese AV; Schmudde I; Ender F; Ströver HA; Vollbrandt T; König P; Laumonnier Y; Köhl J
J Immunol; 2014 Dec; 193(11):5387-401. PubMed ID: 25355927
[TBL] [Abstract][Full Text] [Related]
30. Human plasmacytoid dendritic cells express receptors for anaphylatoxins C3a and C5a and are chemoattracted to C3a and C5a.
Gutzmer R; Köther B; Zwirner J; Dijkstra D; Purwar R; Wittmann M; Werfel T
J Invest Dermatol; 2006 Nov; 126(11):2422-9. PubMed ID: 16778800
[TBL] [Abstract][Full Text] [Related]
31. Targeting C3a/C5a receptors inhibits human mesangial cell proliferation and alleviates immunoglobulin A nephropathy in mice.
Zhang Y; Yan X; Zhao T; Xu Q; Peng Q; Hu R; Quan S; Zhou Y; Xing G
Clin Exp Immunol; 2017 Jul; 189(1):60-70. PubMed ID: 28295247
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of C3a receptor expression on human leucocytes by the use of novel monoclonal antibodies.
Zwirner J; Götze O; Begemann G; Kapp A; Kirchhoff K; Werfel T
Immunology; 1999 May; 97(1):166-72. PubMed ID: 10447728
[TBL] [Abstract][Full Text] [Related]
33. Allergen-induced CD11b+ CD11c(int) CCR3+ macrophages in the lung promote eosinophilic airway inflammation in a mouse asthma model.
Moon KA; Kim SY; Kim TB; Yun ES; Park CS; Cho YS; Moon HB; Lee KY
Int Immunol; 2007 Dec; 19(12):1371-81. PubMed ID: 17977814
[TBL] [Abstract][Full Text] [Related]
34. C5a receptor and interleukin-6 are expressed in tissue macrophages and stimulated keratinocytes but not in pulmonary and intestinal epithelial cells.
Fayyazi A; Sandau R; Duong LQ; Götze O; Radzun HJ; Schweyer S; Soruri A; Zwirner J
Am J Pathol; 1999 Feb; 154(2):495-501. PubMed ID: 10027407
[TBL] [Abstract][Full Text] [Related]
35. Pulmonary injury induced by C3a and C5a anaphylatoxins.
Stimler NP; Hugli TE; Bloor CM
Am J Pathol; 1980 Aug; 100(2):327-48. PubMed ID: 6967702
[TBL] [Abstract][Full Text] [Related]
36. The mouse anaphylatoxin C3a receptor: molecular cloning, genomic organization, and functional expression.
Tornetta MA; Foley JJ; Sarau HM; Ames RS
J Immunol; 1997 Jun; 158(11):5277-82. PubMed ID: 9164946
[TBL] [Abstract][Full Text] [Related]
37. Detection of anaphylatoxin receptors on CD83+ dendritic cells derived from human skin.
Kirchhoff K; Weinmann O; Zwirner J; Begemann G; Götze O; Kapp A; Werfel T
Immunology; 2001 Jun; 103(2):210-7. PubMed ID: 11412308
[TBL] [Abstract][Full Text] [Related]
38. Different doses of lipopolysaccharides regulate the lung inflammation of asthmatic mice via TLR4 pathway in alveolar macrophages.
Dong L; Li H; Wang S; Li Y
J Asthma; 2009 Apr; 46(3):229-33. PubMed ID: 19373628
[TBL] [Abstract][Full Text] [Related]
39. A novel interpretation of immune redundancy and duality in reperfusion injury with important implications for intervention in ischaemic disease.
Thrane AS; Skehan JD; Thrane PS
Med Hypotheses; 2007; 68(6):1363-70. PubMed ID: 17169498
[TBL] [Abstract][Full Text] [Related]
40. Noninvasive quantitative tomography of the therapeutic response to dexamethasone in ovalbumin-induced murine asthma.
Korideck H; Peterson JD
J Pharmacol Exp Ther; 2009 Jun; 329(3):882-9. PubMed ID: 19293392
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
